Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1

Published:2011-10 Issue:5-6 Volume:22 Page:311-319
ISSN:1359-6101
Container-title:Cytokine & Growth Factor Reviews
language:en
Short-container-title:Cytokine & Growth Factor Reviews

Author:

Van Hauwermeiren Filip,Vandenbroucke Roosmarijn E.,Libert Claude

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Endocrinology, Diabetes and Metabolism

Reference113 articles.

1. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia;Tracey;Nature,1987

2. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80kDa tumor necrosis factor receptor;Grell;Cell,1995

3. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies;Kontoyiannis;Immunity,1999

4. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management;Gardam;The Lancet Infectious Diseases,2003

5. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials;Bongartz;JAMA: The Journal of the American Medical Association,2006

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Axial Spondyloarthritis: an overview of the disease;Rheumatology International;2024-04-30

2. Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules;Biomarker Research;2024-03-21

3. Case Report: Insulin hypersensitivity in youth with type 1 diabetes;Frontiers in Endocrinology;2023-10-20

4. Human granzyme B regulatory B cells prevent effector CD4+CD25- T cell proliferation through a mechanism dependent from lymphotoxin alpha;Frontiers in Immunology;2023-07-31

5. Targeting Tumor Necrosis Factor Receptor 1 with Selected Aptamers for Anti-Inflammatory Activity;ACS Applied Materials & Interfaces;2023-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3